Impact of metformin on cardiovascular disease: a meta-analysis of randomised trials among people with type 2 diabetes

Impact of metformin on cardiovascular disease: a meta-analysis of randomised trials among people... Diabetologia (2017) 60:1620–1629 DOI 10.1007/s00125-017-4337-9 REVIEW Impact of metformin on cardiovascular disease: a meta-analysis of randomised trials among people with type 2 diabetes 1,2 1 1 Simon J. Griffin & James K. Leaver & Greg J. Irving Received: 21 April 2017 /Accepted: 24 May 2017 /Published online: 2 August 2017 The Author(s) 2017. This article is an open access publication Abstract control. Summary estimates were based on a small number of Aims/hypothesis Metformin is the most-prescribed oral med- events: 416 myocardial infarctions/ischaemic heart disease ication to lower blood glucose worldwide. Yet previous sys- events in seven studies and 111 strokes in four studies. The tematic reviews have raised doubts about its effectiveness in UK Prospective Diabetes Study (UKPDS) contributed the ma- reducing risk of cardiovascular disease, the most costly com- jority of data to the summary estimates, with weights ranging plication of type 2 diabetes. We aimed to systematically iden- from 52.3% for myocardial infarction to 70.5% for stroke. All tify and pool randomised trials reporting cardiovascular out- outcomes, with the exception of stroke, favoured metformin, comes in which the effect of metformin was ‘isolated’ through with limited heterogeneity between studies, but none achieved comparison to diet, lifestyle or http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Diabetologia Springer Journals

Impact of metformin on cardiovascular disease: a meta-analysis of randomised trials among people with type 2 diabetes

Loading next page...
 
/lp/springer_journal/impact-of-metformin-on-cardiovascular-disease-a-meta-analysis-of-3boWq0f60O
Publisher
Springer Berlin Heidelberg
Copyright
Copyright © 2017 by The Author(s)
Subject
Medicine & Public Health; Internal Medicine; Metabolic Diseases; Human Physiology
ISSN
0012-186X
eISSN
1432-0428
D.O.I.
10.1007/s00125-017-4337-9
Publisher site
See Article on Publisher Site

Abstract

Diabetologia (2017) 60:1620–1629 DOI 10.1007/s00125-017-4337-9 REVIEW Impact of metformin on cardiovascular disease: a meta-analysis of randomised trials among people with type 2 diabetes 1,2 1 1 Simon J. Griffin & James K. Leaver & Greg J. Irving Received: 21 April 2017 /Accepted: 24 May 2017 /Published online: 2 August 2017 The Author(s) 2017. This article is an open access publication Abstract control. Summary estimates were based on a small number of Aims/hypothesis Metformin is the most-prescribed oral med- events: 416 myocardial infarctions/ischaemic heart disease ication to lower blood glucose worldwide. Yet previous sys- events in seven studies and 111 strokes in four studies. The tematic reviews have raised doubts about its effectiveness in UK Prospective Diabetes Study (UKPDS) contributed the ma- reducing risk of cardiovascular disease, the most costly com- jority of data to the summary estimates, with weights ranging plication of type 2 diabetes. We aimed to systematically iden- from 52.3% for myocardial infarction to 70.5% for stroke. All tify and pool randomised trials reporting cardiovascular out- outcomes, with the exception of stroke, favoured metformin, comes in which the effect of metformin was ‘isolated’ through with limited heterogeneity between studies, but none achieved comparison to diet, lifestyle or

Journal

DiabetologiaSpringer Journals

Published: Aug 2, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve Freelancer

DeepDyve Pro

Price
FREE
$49/month

$360/year
Save searches from
Google Scholar,
PubMed
Create lists to
organize your research
Export lists, citations
Read DeepDyve articles
Abstract access only
Unlimited access to over
18 million full-text articles
Print
20 pages/month
PDF Discount
20% off